BidaskClub upgraded shares of Mednax, Inc (NYSE:MD) from a sell rating to a hold rating in a research note published on Friday.
Other equities research analysts also recently issued reports about the company. Jefferies Group LLC reaffirmed a hold rating and set a $58.00 target price on shares of Mednax in a report on Wednesday, April 26th. Mizuho reduced their target price on Mednax from $64.00 to $58.00 and set a neutral rating for the company in a report on Tuesday, May 30th. TheStreet downgraded Mednax from a b- rating to a c+ rating in a report on Tuesday, May 16th. Stephens raised Mednax from an equal weight rating to an overweight rating and upped their target price for the company from $55.00 to $68.00 in a report on Thursday, June 22nd. Finally, Stifel Nicolaus reduced their target price on Mednax from $65.00 to $58.00 and set a hold rating for the company in a report on Thursday, May 25th. One analyst has rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company. Mednax presently has an average rating of Hold and an average price target of $66.44.
Shares of Mednax (NYSE:MD) opened at 59.63 on Friday. The company’s 50-day moving average price is $55.76 and its 200-day moving average price is $64.91. The stock has a market cap of $5.51 billion, a PE ratio of 17.80 and a beta of 0.52. Mednax has a 52-week low of $53.80 and a 52-week high of $76.96.
Mednax (NYSE:MD) last announced its earnings results on Thursday, May 4th. The company reported $0.75 EPS for the quarter, beating the consensus estimate of $0.74 by $0.01. Mednax had a return on equity of 12.81% and a net margin of 9.54%. The business had revenue of $835.60 million during the quarter, compared to the consensus estimate of $837.01 million. During the same period in the prior year, the business posted $0.87 earnings per share. Mednax’s revenue was up 11.0% compared to the same quarter last year. Analysts expect that Mednax will post $3.61 earnings per share for the current year.
TRADEMARK VIOLATION WARNING: “Mednax, Inc (MD) Raised to Hold at BidaskClub” was first reported by sleekmoney and is the property of of sleekmoney. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://sleekmoney.com/mednax-inc-md-raised-to-hold-at-bidaskclub/1946077.html.
In related news, CFO Vivian Lopez-Blanco sold 7,778 shares of the stock in a transaction dated Friday, May 5th. The stock was sold at an average price of $55.82, for a total value of $434,167.96. Following the completion of the sale, the chief financial officer now directly owns 51,319 shares of the company’s stock, valued at approximately $2,864,626.58. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Md Pascal J. Goldschmidt sold 1,969 shares of the stock in a transaction dated Wednesday, June 14th. The stock was sold at an average price of $57.57, for a total value of $113,355.33. Following the completion of the sale, the director now directly owns 18,072 shares of the company’s stock, valued at $1,040,405.04. The disclosure for this sale can be found here. Over the last three months, insiders sold 33,074 shares of company stock valued at $1,830,508. Company insiders own 2.40% of the company’s stock.
A number of large investors have recently made changes to their positions in MD. Ladenburg Thalmann Financial Services Inc. increased its stake in shares of Mednax by 5.0% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 1,604 shares of the company’s stock valued at $106,000 after buying an additional 77 shares in the last quarter. Ledyard National Bank increased its stake in shares of Mednax by 19.0% in the first quarter. Ledyard National Bank now owns 1,725 shares of the company’s stock valued at $120,000 after buying an additional 275 shares in the last quarter. Pacer Advisors Inc. increased its stake in shares of Mednax by 3.2% in the first quarter. Pacer Advisors Inc. now owns 1,795 shares of the company’s stock valued at $125,000 after buying an additional 55 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its stake in shares of Mednax by 870.9% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,000 shares of the company’s stock valued at $139,000 after buying an additional 1,794 shares in the last quarter. Finally, Morgan Dempsey Capital Management LLC increased its stake in shares of Mednax by 3.6% in the first quarter. Morgan Dempsey Capital Management LLC now owns 2,270 shares of the company’s stock valued at $157,000 after buying an additional 78 shares in the last quarter.
Mednax Company Profile
MEDNAX, Inc is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, the Company’s national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications.
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/mednax-inc-md-raised-to-hold-at-bidaskclub/1946077.html
Receive News & Ratings for Mednax Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mednax Inc and related companies with MarketBeat.com's FREE daily email newsletter.